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Obesity is recognized as a significant risk factor for Alzheimer’s disease (AD). Studies
have supported the notion that obesity accelerates AD-related pathophysiology in
mouse models of AD. The majority of studies, to date, have focused on the use of
early-onset AD models. Here, we evaluate the impact of genetic risk factors on lateonset AD (LOAD) in mice fed with a high fat/high sugar diet (HFD). We focused on three
mouse models created through the IU/JAX/PITT MODEL-AD Center. These included
a combined risk model with APOE4 and a variant in triggering receptor expressed on
myeloid cells 2 (Trem2R47H ). We have termed this model, LOAD1. Additional variants
including the M28L variant in phospholipase C Gamma 2 (Plcg2M28L ) and the 677C > T
variant in methylenetetrahydrofolate reductase (Mthfr 677C > T ) were engineered by
CRISPR onto LOAD1 to generate LOAD1.Plcg2M28L and LOAD1.Mthfr 677C > T . At 2
months of age, animals were placed on an HFD that induces obesity or a control diet
(CD), until 12 months of age. Throughout the study, blood was collected to assess the
levels of cholesterol and glucose. Positron emission tomography/computed tomography
(PET/CT) was completed prior to sacrifice to image for glucose utilization and brain
perfusion. After the completion of the study, blood and brains were collected for
analysis. As expected, animals fed a HFD, showed a significant increase in body weight
compared to those fed a CD. Glucose increased as a function of HFD in females only
with cholesterol increasing in both sexes. Interestingly, LOAD1.Plcg2M28L demonstrated
an increase in microglia density and alterations in regional brain glucose and perfusion
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on HFD. These changes were not observed in LOAD1 or LOAD1.Mthfr 677C > T animals
fed with HFD. Furthermore, LOAD1.Plcg2M28L but not LOAD1.Mthfr 677C > T or LOAD1
animals showed transcriptomics correlations with human AD modules. Our results show
that HFD affects the brain in a genotype-specific manner. Further insight into this process
may have significant implications for the development of lifestyle interventions for the
treatment of AD.
Keywords: Alzheime’s disease, transcriptomics, diet, obesity, genetic risk alleles, predisposition

2021). The APOE4 is the greatest genetic risk factor for
LOAD which is thought to increase the risk for AD through
both gain and loss of function effects on multiple processes
in the brain including amyloid clearance, synaptic plasticity,
and cerebrovascular health (Liu et al., 2013). The TREM2R47H
is a rare coding mutation with a partial loss of function
that alters the behavior of microglia (Carmona et al., 2018).
LOAD1 mice and controls were aged 24 months and data
showed age but not genotype was the major factor-driving
changes in LOAD1 mice (Kotredes et al., 2021). Therefore,
these mice provided a sensitized background for assessing
additional genetic and environmental risk factors (Kotredes
et al., 2021). To further sensitize LOAD1 mice, additional
LOAD genetic risk factors were added via CRISPR/CAS9.
These included the M28L variant in phospholipase C Gamma
2 (Plcg2M28L ) (Tsai et al., 2021) and the 677C > T variant
in methylenetetrahydrofolate reductase (Mthfr677C > T ) (Wang
et al., 2005; Chan et al., 2019). The PLCG2 gene encodes an
enzyme that catalyzes the conversion of phospholipid PIP2
(1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate) to IP3 (1Dmyo-inositol 1,4,5-trisphosphate) and DAG (diacylglycerol).
PLCG2 plays a crucial role in signal transduction between
tyrosine kinases and downstream events, protein kinase C
activation, and intracellular calcium release (Hernandez et al.,
1994). In the CNS, PLCG2 is involved in TREM2/TYROBP
signaling pathway and is selectively expressed in microglia,
playing important roles in inflammation, phagocytosis, and
lipid sensing. Although the precise effects of the M28L
variant have not yet been elucidated, like TREM2, PLCG2
is expressed by microglia and plays a role in amyloid
clearance (Carmona et al., 2018). MTHFR functions in the
folate/methionine/homocysteine pathway are expressed both
peripherally and centrally, and the MTHFR677C > T variant
causes an increase in homocysteine increasing the risk for a
variety of diseases including cardiovascular and cerebrovascularrelated disorders and AD (Liu et al., 2010; Liew and Gupta,
2015; Rai, 2017). Transcriptomic analyses of the brain tissue
from LOAD1.Plcg2M28L or LOAD1.Mthfr677C > T mice revealed
increased alignment to brain transcriptomes from human
patients with AD compared to B6 or LOAD1 controls (Preuss
et al., 2020).
Despite carrying multiple genetic risk variants for LOAD,
LOAD1, LOAD1.Plcg2M28L , and LOAD1.Mthfr677C > T
did not natively recapitulate all phenotypes relevant to
LOAD, making these strains ideal to test the effects of
environmental risk factors, such as diet. Commonly, the

INTRODUCTION
Genetic and genome-wide association studies have identified
variations in numerous genes that increase the risk for lateonset AD (LOAD). The E4 allele of apolipoprotein E (APOE4)
is the greatest genetic risk factor but with variations in
many other genes, including triggering receptor expressed on
myeloid cells 2 (TREM2), also contribute to risk. Importantly,
unlike relatively rare cases of familial AD (fAD), which are
predominantly caused by mutations in APP or one APP
processing gene, no single LOAD-associated variant is sufficient
to cause AD. It is anticipated that combinations of genetic
risk factors are required to develop LOAD. Studies also suggest
that genetic factors may only contribute between 50 and
70% of the risk for LOAD, meaning many individuals are
likely to develop LOAD due to a combination of genetic and
environmental factors (Kawahara et al., 2017; Sarkar et al.,
2019; Rahman et al., 2020; Kim et al., 2021). Studies have
shown that diet, obesity, cardiovascular diseases, hypertension,
physical activity, diabetes, educational attainment, smoking,
and traumatic brain injury increase the risk for LOAD and
other dementias (Ebbert et al., 2014; Baumgart et al., 2015;
Xu et al., 2015; Wajman et al., 2018). Some of these risk
factors can be attributed to a balance between diet and exercise.
For instance, a western-style diet (e.g., a high fat/high sugar
diet (HFD), and low in vitamins) in combination with a
sedentary lifestyle can contribute to a metabolic syndrome, a
cluster of conditions that includes increased blood pressure,
high blood sugar, obesity, particularly excess body fat around
the waist, and abnormal cholesterol or triglyceride levels.
Metabolic syndrome increases the risk for Type 2 diabetes
and cardiovascular disease, and AD (Kivipelto et al., 2001;
Luchsinger et al., 2004; Cordain et al., 2005; Whitmer et al.,
2008).
The Model Organism Development and Evaluation for Lateonset AD (MODEL-AD) consortium was established to develop
mouse models that more faithfully develop LOAD-relevant
phenotypes compared to previous mouse models that were
largely based on fAD. Two centers, one from the Indiana
University (IU), the Jackson Laboratory (JAX), the University
of Pittsburgh (PITT), and Sage Bionetworks, and the other
from the University of California Irvine (UCI), have focused
on incorporating genetic risk factors into C57BL/6J (B6)
mice and assaying human-relevant phenotypes. Initially, the
IU/JAX/PITT group created mice that are double homozygous
for APOE4 and Trem2R47H (termed LOAD1) (Kotredes et al.,
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into
LOAD1
mice.B6.Mthfr677C > T /APOE4/Trem2R47H
(triple homozygous, LOAD1.Mthfr677C > T , JAX ID:30922),
was also created using CRISPR/Cas9 to introduce the
677TC > T variant into LOAD1 mice (Reagan et al., 2021).
All strains were validated using brain RNA-seq to confirm
no off-target effects and no alterations in target transcript
isoforms/expression levels (Kotredes et al., 2021). More
details on strain creation are provided on the AD Knowledge
Portal.1
The effects of HFD on LOAD1.Plcg2M28L mice were assessed
at the Indiana University (IU), with LOAD1.Mthfr677C > T mice
assessed at JAX. LOAD1 mice acted as site-matched controls. An
additional cohort of B6 mice was assessed at IU as a strain control.
At IU, for experimental cohorts, LOAD1.Plcg2M28L/+ mice were
intercrossed to create LOAD1.Plcg2M28L triple homozygous and
LOAD1 litter-matched control mice. At JAX, for experimental
cohorts, LOAD1.Mthfr677TC > T/+ mice were intercrossed to
create LOAD1.Mthfr677TC > T triple homozygous and LOAD1
litter-matched control mice. Up to five mice were housed per
cage with SaniChip bedding and were initially provided with
LabDiet 5K52/5K67 (6% fat, control diet, CD2 ). Mouse rooms
were kept on a 12:12 light:dark schedule with the lights on
from 7:00 a.m. (6:00 a.m. at JAX) to 7:00 p.m. daily (6:00
p.m. at JAX). Mice were initially ear-punched for identification
and then following genotype confirmations, microchipped using
a p-chip system (PharmaSeq), with the microchips placed at
the base of the tail. At 2 months of age (mos), experimental
cohorts were randomized into two groups: Group 1 continued
on CD ad libitum and Group 2 was provided with ResearchDiet
feed D12451i (45% of high fat; 35% of carbohydrates, HFD3 )
ad libitum. All procedures were approved by the IU or JAX
Institutional Animal Care and Use Committees (IACUC). Where
possible, all housing and procedures were standardized and
aligned across sites. Unless specified, n = 10 for each sex,
genotype, and diet were used.
Mice were anesthetized to the surgical plane of anesthesia with
tribromoethanol at 12 months of age. Under complete anesthesia,
animals were euthanized by decapitation and perfused through
the heart with ice-cold phosphate-buffered saline (PBS). Blood
and trunk blood was centrifuged for 15–20 min at 4◦ C at 14,500
RPM, and the plasma was stored at –80◦ C.

diet consumed by the western world is high in fat and refined
sugar. This has led to a global obesity epidemic where, for
instance, 42% of all Americans are considered overweight
(The Center For Disease Control And Prevention, 2022).
Obesity can cause a wide range of changes including increased
inflammation in both the periphery and the brain (Ellulu
et al., 2017; Chan et al., 2019). Inflammation is characterized,
in part by increased production of cytokines, such as IL1b
and the activation of myeloid cells, including microglia
in the brain (Wang et al., 2015). Chronic inflammation
has been shown to greatly increase the risk for LOAD
(Furman et al., 2019).
Multiple studies in mice have assessed the effects of a
western-like diet in the context of aging and AD. For instance,
a study showed a diet-induced myelin breakdown in aging
B6 mice that were dependent on the complement cascade
(Graham et al., 2020). Also, the addition of an HFD exacerbated
AD phenotypes in mouse models relevant to early-onset AD
(Knight et al., 2014; Jones et al., 2019; Bracko et al., 2020;
Robison et al., 2020; Jones et al., 2021). In one study, Jones
et al. (2019) found that with HFD, male APOE4 mice were
more susceptible to metabolic disturbances, including glucose
intolerance when compared to APOE3 mice. Behavioral deficits
were not observed due to HFD, suggesting that metabolic
responses to HFD are dependent on both sex and APOE
genotype. A second study concluded that early dysregulation
of inflammation in APOE4 brains could predispose to CNS
damage from various insults, including diet, and later results
in the increased CNS damage normally associated with the
APOE4 genotype (Jones et al., 2021). However, the effects of
a western-like diet in the context of multiple genetic risk
factors for LOAD have not been studied. To address this,
a commonly used HFD (high in fat and sugar, refer to
the section, Methods) was fed to male and female LOAD1,
LOAD1.Plcg2M28L , and LOAD1.Mthfr677C > T mice from 2 to
12 months. Biometric measures were collected throughout
the study, in vivo imaging to assess glucose utilization and
blood perfusion in a region-specific manner in the brain
was carried out prior to perfusion, and brain transcriptomics,
neuropathological assessments, and protein quantification were
performed postmortem. Results showed that the effects of
consumption of HFD to midlife were not uniform across
all models but dependent on specific genetic risk factors. In
particular, the effects of the HFD were most severe in the presence
of Plcg2M28L .

R

R

Blood Plasma Analysis, Perfusion, and
Preparation of Tissue Samples
Blood was collected longitudinally from fasting mice at 8 months
of age via a cheek puncture and again at the terminal timepoint
of 12 months of age where mice were anesthetized, and blood
was extracted through a left ventricle cardiac puncture with
a 25 g of EDTA-coated needle before PBS perfusion. Brain
tissue was collected immediately after euthanasia. Approximately
500 mL of whole blood was transferred to a MAP-K2 EDTA
Microcontainer (BD, Franklin Lakes, NJ, United States) on

MATERIALS AND METHODS
Animal Housing Conditions at Indiana
University and the Jackson Laboratory
All animals were obtained from the JAX and are congenic
to the C57BL/6J (JAX# 000664) (B6) strain. LOAD1 is
homozygous for both APOE4 and Trem2R47H (JAX ID:28709).
B6.Plcg2M28L /APOE4/Trem2R47H
(triple
homozygous,
LOAD1.Plcg2M28L , JAX ID:30674) was created using
CRISPR/Cas9 to introduce the M28L LOAD risk variant
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ice and centrifuged at 4◦ C at 4388 × g in a pre-chilled
ultracentrifuge for 15 min. Without disturbing the red blood
cell fraction, serum supernatant was pipetted into a chilled
cryovial with a p200 tip and immediately snap-frozen on
dry ice for 10 min. Samples were stored at –80◦ C and later
thawed for the analysis of glucose, total cholesterol, low-density
lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride,
and non-essential fatty acid (NEFA) levels with the Siemens
Advia 120 (Germany).

spectrophotometer (Thermo Fisher Scientific) and the
RNA Total RNA Nano assay (Agilent Technologies, Santa
Clara, CA, United States). The NanoString Mouse AD gene
expression panel was used for gene expression profiling on the
nCounter platform (NanoString, Seattle, WA, United States)
as described by the manufacturer. The nSolver software
was used for generating raw NanoString gene expression
values. The NanoString data were normalized by dividing
raw counts within a lane by the geometric mean of the
housekeeping genes from the same lane (Preuss et al., 2020).
Next, normalized count values were log-transformed for
downstream analysis.
The NanoString gene expression data were generated
for male and female LOAD1, LOAD1.Plcg2M28L , and
LOAD1.Mthfr677C > T mice fed on standard chow diet and
HFD. We assessed the effects of sex, HFD, each genetic variant
(Mthfr677C > T , Plcg2M28L ), the interaction between HFD and
Mthfr677C > T , and the interaction between HFD and Plcg2M28L .
To determine the effects of each of these factors, we fit a multiple
regression model using the lm function in R as (Pandey et al.,
2019):

Histology and Fluorescent
Immunostaining
After perfusion and dissection, the left side of each mouse brain
was fixed in 4% of paraformaldehyde. After a transfer to 10%
sucrose the following day, the brains were transferred to 30% of
sucrose for storage. Brains were sectioned, coronally (Jax) and
sagittally (IU), at 10–20 µm on a freezing microtome.

NeuN Staining
Sections were washed and blocked for 1 h in 10% of host
goat serum. Sections were incubated overnight at 4◦ C in
a solution containing the antibody, NeuN rabbit (ab104225,
1:1,000, Abcam). After additional washes, the sections were
incubated for 1 h at room temperature in a secondary solution
containing the fluorescent markers, goat anti-rabbit 488 (A11034,
1:1,000, Invitrogen). After one additional wash, the sections were
mounted on charged slides, counterstained, and coverslipped
with Prolong Gold Antifade Mountant with DAPI.

Log(expr) = β0 +

βi + ε

i

Where the sum is over sex (male), HFD, genetic variants
(Mthfr677C > T , Plcg2M28L ), and interaction terms between HFD
and each variant (HFD∗ Mthfr677C > T , HFD∗ Plcg2M28L ). The
log(expr) represents the log-transformed normalized count from
the NanoString gene expression panel (Preuss et al., 2020). In
this formulation, the standard chow diet and LOAD1 genetic
background serve as controls. The values, β0 and ε represent the
average expression level for the reference LOAD1 male mice on
the standard chow diet and residual, respectively.
Next, we have computed Pearson’s correlation between
gene expression changes (log-fold change) in human cases
with AD vs. controls in each AMP-AD module (Greenwood
et al., 2020) and the effect of each mouse perturbation
(sex, HFD, Mthfr677C > T , Plcg2M28L , and interaction terms
HFD∗ Mthfr677C > T , HFD∗ Plcg2M28L ) as measured above for
each gene in NanoString panel (Pandey et al., 2019; Preuss et al.,
2020) using cor.test function built in R as:

Iba1 Staining
Sections were washed and then blocked with 10% of host goat
serum for 2 h. Sections were incubated overnight at 4◦ C in a
solution containing the Recombinant Anti-Iba1 antibody rabbit
(ab178847, 1:500, Abcam). After additional washes, the sections
were incubated for 1 h at room temperature in a secondary
solution containing the fluorescent markers, goat anti-rabbit 488
(A11034, 1:1000, Invitrogen). After one additional wash, the
sections were mounted on charged slides, counterstained, and
coverslipped with Prolong Gold Antifade Mountant with DAPI.
Microscopy was used to view and capture images of the
immunofluorescent stains with a Leica DM6 B and DFC7000
GT camera using Leica Microsystems’ LAS X software. Further
image capture and image scanning were performed on an Andor
Zyla 5.5 sCMOS camera with an Aperio Versa scanner and
Versa software. One to three coronal (LOAD1.Mthfr677C > T ) or
sagittal (LOAD1.Plcg2M28L ) sections were analyzed with Imaris
software to generate density measurements within the cortex and
subiculum (Supplementary Figure 1A).

cor.test(Log 2 FC(AD/control), β)
from which we obtained both the correlation coefficient and the
significance level (p-value) of the correlation. Log2 FC values for
human transcripts were obtained through the AD Knowledge
Portal (Greenwood et al., 2020).4
Similarly, we have computed Pearson’s correlation between
gene expression changes (log-fold change) in human AD
cases versus controls in each of the LOAD subtypes (Milind
et al., 2020) and the effect of each mouse perturbation
(sex, HFD, Mthfr677C > T , Plcg2M28L , interaction terms
HFD∗ Mthfr677C > T , and HFD∗ Plcg2M28L ) for each gene in

RNA Extraction and Nanostring Analysis
As previously described (Preuss et al., 2020; Oblak et al.,
2021), total RNA was extracted from frozen right brain
hemispheres using the MagMAX mirVana Total RNA Isolation
Kit (Thermo Fisher Scientific) and the KingFisher Flex
purification system (Thermo Fisher Scientific, Waltham,
MA; n = 6 per sex/genotype/diet). RNA concentration
and quality were assessed using the Nanodrop 2000
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hippocampus due to their relevance to LOAD neuropathology
across independent human cohorts (ROS/MAP, Mount Sinai
Brain Bank, and Mayo Clinic) and stratified patients into different
molecular subtypes based on gene co-expression profiles using
iterative WGCNA (Allen et al., 2016; De Jager et al., 2018; Wang
et al., 2018). Two distinct LOAD subtypes were identified in the
ROSMAP cohort, three LOAD subtypes were identified in the
Mayo cohort, and two distinct LOAD subtypes were identified in
the MSBB cohort. Similar subtype results were observed in each
cohort, with LOAD subtypes found to primarily differ in their
inflammatory response based on differential expression analysis
(Milind et al., 2020).

Nanostring panel (Pandey et al., 2019; Preuss et al., 2020) using
cor.test function built in R as:
cor.test(Log 2 FC(LOADSubtype/control), β)
from which we obtained both the correlation coefficient
and the significance level (p-value) of the correlation. Here,
Log2 FC(LOAD Subtype/control) represents the log-fold change
in gene expression in each subtype vs. control.
We plotted the correlation results using the ggplot2 package
in R. Circles within a square correspond to significant
(p < 0.05) positive (blue) and negative (red) Pearson’s correlation
coefficients. The color intensity and size of the circles are
proportional to Pearson’s correlation coefficient.

Kyoto Encyclopedia of Genes and
Genomes Pathway Enrichment Analysis

Human Post-mortem Brain Cohorts and
Gene Co-expression Modules

Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway
enrichment analysis was performed using clusterprofiler package
(Yu et al., 2012) within the R software environment. Pathways
were determined to be significant after multiple testing
corrections (FDR adjusted p < 0.05). Gene set enrichment
analysis (GSEA) was used based on the method proposed by
Subramanian et al. (2005) as implanted in the clusterProfiler
package for the KEGG pathway library. Nanostring AD panel
genes were ranked based on regression coefficients calculated
for each factor (sex, high fat diet, Mthfr677C > T , Plcg2M28L ,
interaction terms HFD∗ Mthfr677C > T , and HFD∗ Plcg2M28L ).
Enrichment scores for all KEGG pathways were computed to
compare relative expression on the pathway level between each
factor. Principal component analysis (PCA) was performed using
the resulting gene set normalized enrichment scores (NES).

Wan et al. (2020) discovered 30 human brain co-expression
modules based on the meta-analysis of differential gene
expression from seven distinct regions: the dorsolateral
prefrontal cortex (DLPFC), superior temporal gyrus (STG),
frontal pole (FP), parahippocampal gyrus (PHG), temporal
cortex (TCX), inferior frontal gyrus (IFG), and the cerebellum
(CBE) in postmortem samples obtained from three independent
LOAD cohorts: the Religious Orders Study and the Memory
and Aging Project (ROSMAP) cohort, the Mount Sinai Brain
Bank (MSBB), and the Mayo Clinic cohort (Allen et al., 2016; De
Jager et al., 2018; Wang et al., 2018). Briefly, Wan et al. (2020)
performed library normalization and covariate adjustments for
each human study separately using fixed/mixed effects modeling
to account for batch effects. Initially, a total of 2,978 brain regions’
specific expression modules were identified across all tissues
(doi: 10.7303/syn10309369.1) using five distinct network module
identification algorithms (MEGENA, WINA, metanetwork,
rWGCNA, and speakEasy). Next, 660 modules were selected
that were significantly enriched for at least one AD-specific
differentially expressed gene set from the meta-analysis. Lastly,
the graph clustering method was applied to identify 30 aggregate
modules that are not only differentially expressed but are also
replicated across multiple independent co-expression module
algorithms (Wan et al., 2020). Wan et al. classified these 30
aggregate co-expression modules into five distinct consensus
clusters (Wan et al., 2020). These consensus clusters consist of
a subset of modules that are associated with similar AD-related
changes across the multiple studies and brain regions. Reactome
pathway5 enrichment analysis was used to identify specific
biological themes across these five consensus clusters. Pathways
were ranked based on their Bonferroni corrected p-values to
account for multiple testing. Finally, consensus clusters were
annotated based on the highest ranked and non-overlapping
term for each functionally distinct cluster.

In vivo PET/CT Imaging
To assess regional glycolysis and tissue perfusion, mice were noninvasively imaged via PET/CT (n = 10 mice/sex/genotype/age).
To measure the regional blood flow, copper-pyruvaldehydebis(N4-methylthiosemicarbazone) (64 Cu-PTSM)(Green, 1987),
which has a very high first pass (>75%) extraction (Mathias
et al., 1991) and glutathione reductase redox trapping of copper
(Mathias et al., 1991), was administered via tail vein in awake
subjects and was given a 2 min uptake period prior to imaging. To
measure regional glycolytic metabolism, 2-fluoro-2-deoxyglucose
(18 F-FDG) was administered via tail vein in awake subjects and
given a 30 min uptake period prior to imaging. Post uptake,
mice were induced with 5% of isoflurane (95% medical oxygen)
and maintained during acquisition with 1–2% of isoflurane
at 37◦ C. To provide both anatomical structure and function,
PET/CT imaging was performed with a Molecubes b-X-CUBE
system (Molecubes NV, Gent Belgium). For PET determination
of blood flow and metabolism, calibrated listmode PET images
were acquired on the b-CUBE and reconstructed into a singlestatic image using ordered subset expectation maximization
(OSEM) with 30 iterations and 3 subsets (Krishnamoorthy et al.,
2018). To provide anatomical reference and attenuation maps
necessary to obtain fully corrected quantitative PET images,
helical CT images were acquired with tube voltage of 50
kV, 100 mA, 100 µm slice thickness, 75 ms exposure, and

Human LOAD Subtypes
Milind et al. (2020), integrated post-mortem brain gene coexpression data from the frontal cortex, temporal cortex, and
5

https://reactome.org/

Frontiers in Aging Neuroscience | www.frontiersin.org

5

June 2022 | Volume 14 | Article 886575

Plcg2M28L Interacts With Diet AD

Oblak et al.

100 µm resolution. In all cases, images were corrected for
radionuclide decay, tissue attenuation, detector dead-time loss,
and photon scatter according to the manufacturer’s methods
(Krishnamoorthy et al., 2018). Post-acquisition, all PET and CT
images were co-registered using a mutual information-based
normalized entropy algorithm (Studholme et al., 1998) with 12
degrees of freedom and mapped to stereotactic mouse brain
coordinates (Franklin and Paxinos, 2013). Finally, to quantify
regional changes, voxels of interest (VOIs) for 27 brain (54
bilateral) regions were extracted and analyzed for standardized
uptake value ratios (SUVRs) according to published methods
(Dandekar et al., 2007).

phosphor screen at bregma 0.38, -1.94, and -3.8 mm using
MCID (InterFocus Ltd.). To permit dose and brain uptake
normalization, SUVRs relative to the cerebellum were computed
for PET and autoradiograms for each subject, genotype, and age
as follows:
R(s, g, a)
SUVR(s, R, g, a) =
C(s, g, a)
where, s, g, a, R, and C are the subject, genotype, age,
region/volume of interest, and cerebellum region/volume of
interest. In all cases, the region/volumes of interest were
subjected to PCA analysis, and regions that explain the top
80% of the variance were analyzed for differences with time
and genotype using a two-way ANOVA (Prism, GraphPad Inc.),
where significance was taken at p < 0.05.

Autoradiography
To provide secondary confirmation of the in vivo PET images,
and to quantify tracer uptake regionally, the brains were extracted
post rapid decapitation, gross sectioned along the midline, slowly
frozen on dry ice, then embedded in cryomolds with optimal
cutting temperature (OCT) compound (Tissue-Tek). Thin frozen
sections (20 µm) were obtained via cryotomy at prescribed
bregma targets (n = 6 bregma/mouse, 6 replicates/bregma)
according to stereotactic mouse brain coordinates (Franklin and
Paxinos, 2013). Sections were mounted on glass slides, air dried,
and exposed on BAS Storage Phosphor Screens (SR 2040 E, Cytiva
Inc.) for up to 12 h. The post-exposure, screens were imaged
via Typhoon FL 7000IP (GE Medical Systems) phosphor-imager
at 25 µm resolution along with custom 18F or 64 Cu standards
described previously (Territo et al., 2017).

Homogenization and Protein Extraction
Each hemibrain was weighed prior to homogenizing in tissue
protein extraction reagent (T-PER Thermo Fisher Scientific; 1 mL
per 100 mg of tissue weight) supplemented with protease and
phosphatase inhibitors cocktail (Sigma-Aldrich). Total protein
concentration was measured using bicinchoninic acid (BCA;
Pierce). Hemibrain lysates were then aliquoted and kept in the –
80◦ C freezer for long-term storage. The primary supernatant was
utilized to analyze the content of proinflammatory cytokines.

Cytokine Panel Assay
Mouse hemibrain samples were assayed in duplicate using
the MSD Proinflammatory Panel I (K15048D; MesoScale
Discovery, Gaithersburg, MD, United States), a highly sensitive
multiplex enzyme-linked immunosorbent assay (ELISA). This
panel quantifies the following 10 proinflammatory cytokines in
a single small sample volume (25 µL) of supernatant using an
electrochemiluminescent detection method (MSD): interferon γ
(IFN-γ), interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL12p70, IL-13, and tumor necrosis factor α (TNFα). The mean
intra-assay coefficient for each cytokine was less than 8.5%, based
on the cytokine standards. Any value below the lower limit of
detection (LLOD) for the cytokine assay was replaced with 1/2
LLOD of the assay for statistical analysis.

Image Analysis
All PET and MRI images were co-registered using a ridgedbody mutual information-based normalized entropy algorithm
(Studholme et al., 1997) with 12 degrees of freedom and
mapped to stereotactic mouse brain coordinates (Franklin
and Paxinos, 2013) using MIM 7.0.5 (MIM Software Inc.,
Beachwood, OH, United States). Post-registration, 56 bilateral
regions were extracted via brain atlas and averaged to yield
27 unique volumes of interest that map to key cognitive
and motor centers that include the agranular insular cortex,
auditory cortex, caudate putamen, cerebellum, cingulate cortex,
corpus callosum, dorsolateral orbital cortex, dorsintermed
entorhinal cortex, dysgranular insular cortex, ectorhinal
cortex, fornix, frontal association cortex, hippocampus, lateral
orbital cortex, medial orbital cortex, parietal cortex, parietal
association cortex, perirhinal cortex, prelimbic cortex, primary
motor cortex, primary somatosensory cortex, retrosplenial
dysgranular cortex, secondary motor cortex, secondary
somatosensory cortex, temporal association cortex, thalamus,
ventral orbital cortex, and visual cortex. For autoradiographic
analysis, tracer uptake was quantified on hemi-coronal sections
by manually drawing regions of interest for 17 regions of interest
(i.e., the auditory cortex, caudate putamen, cerebellum, cingulate
cortex, corpus callosum, dorso-intermed entorhinal cortex,
dysgranular insular cortex, ectorhinal cortex, hippocampus,
hypothalamus, medial septum, primary motor cortex, primary
somatosensory cortex, retrosplenial dysgranular cortex, temporal
association cortex, thalamus, and visual cortex) on calibrated
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Data Analysis and Study Design
For biometric studies where multiple samples were collected at
multiple time points for a mouse, a mixed ANOVA for repeated
measures was done. For IHC and cytokine analyses, a two-way
ANOVA was completed, followed by Tukey’s post hoc testing.
For these studies, p < 0.05 was considered significant. Multiple
cohorts of animals were utilized in this study for different
outcome measures, a summary of mouse numbers can be found
in Supplementary Figure 1B.

RESULTS
Chronic Consumption of HFD-Induced
Features of Metabolic Syndrome
This study consisted of three mouse strains, LOAD1,
LOAD1.Mthfr677C > T , and LOAD1.Plcg2M28L on either a normal
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cells in the cortex of female LOAD1.Plcg2M28L mice fed on
HFD compared to LOAD1.Plcg2M28L on CD (Figure 3 and
Supplementary Figure 1). These data are not collected based
on stereological analyses and are therefore suggestive of a
reduced density of IBA1+ cells. Interestingly, we did not see a
difference in LOAD1.Mthfr677C > T mice (Figure 3), suggesting
an HFD-induced neuroinflammatory reaction that is specific to
the LOAD1.Plcg2M28L genotype.

control diet (6%, CD) or an HFD (45%). LOAD1.Plcg2M28L and
LOAD1 mice were assessed at IU and LOAD1.Mthfr677C > T
and LOAD1 mice were assessed at JAX. LOAD1 acted as
site-matched controls. For both studies, HFD was introduced
at 2 months of age in half of the animals, while the other
half was maintained on CD (Figure 1A, refer to Methods
for breeding strategies). Bodyweight was monitored once
a month for the LOAD1.Mthfr677C > T study (Figure 1B)
and once every two months for the LOAD1.Plcg2M28L study
(Figure 1C). Mice fed on HFD gained more weight compared
to those fed on CD, irrespective of genotype (Figures 1B,C).
These data are consistent with the induction of diet-induced
obesity (DIO) that has been previously reported for B6
mice (Wanrooy et al., 2018). Blood samples were collected
from fasting, non-anesthetized mice at 8 (mid stage) and
12 (end stage) months of age to determine glucose and
total cholesterol levels (Figures 1D–G). In general, blood
glucose levels were slightly lower in all mice housed at JAX
(Figure 1D) compared to IU (Figure 1E) which may be due
to differences in environment, despite efforts to standardize
housing conditions. In both studies, there was a significant
effect of HFD in female, but not male mice fed on HFD. The
effect was more striking in female mice from IU (p < 0.0001)
compared to female mice from JAX (p = 0.165). Fasting blood
glucose levels only exceeded 240 mg/dL (a level that previous
studies consider B6 mice to be diabetic (Xiang et al., 2021)
in mice fed with LOAD1 HFD and LOAD1.Plcg2M28L HFD.
Fasting serum cholesterol levels were consistently elevated at
both 8 and 12 months of age in all strains fed with an HFD
compared to those fed with CD independent of genotype and
sex (p > 0.0001 at JAX, p > 0.0001 at IU; Figures 1F–G).
Collectively, these data suggest HFD-induced features of some
metabolic syndrome, potentially in a sex-specific manner, but
independent of genotype.

Plasma Cytokines and Brain Cytokines
Are Altered in HFD Animals
Based on the specific interaction between the LOAD1.Plcg2M28L
mice and the HFD in microglia density, we sought to identify
cytokines in the brain or periphery that may be driving this
interaction. Analysis of cytokines in the brain revealed increases
of IL-1β in HFD fed-LOAD1 animals (Figure 4A); however, the
same changes were not observed in the LOAD1.Mthfr677C > T
animals. In addition, a significant increase in TNF-a was observed
in LOAD1 males but not in females (Figure 4C). No changes in
IFN-γ were observed in the LOAD1. Mthfr677C > T study.
In LOAD1.Plcg2M28L , we found significant reductions in
several proinflammatory cytokines (IL-1β, IFN-γ) in the brain
regardless of diet which was inversely correlated with plasma
(Figures 4D–F). Female LOAD1 animals had an increase in
plasma IL-1β in response to an HFD that was not observed
in males. In contrast, in the plasma of LOAD1.Plcg2M28L
mice, we found a significant increase in TNF-a (Figure 4I)
in mice fed on HFD. However, there was a reduction in IL1β (LOAD1.Plcg2M28L males) and IFN-γ (LOAD1.Plcg2M28L
females), suggesting that there is a difference in the peripheral
and central immune responses to an HFD.

Neuron Number Was Unchanged but
Reactive Microglia Increased in
LOAD1.Plcg2M28L Animals

Interaction Between Risk Variant
Plcg2M28L and HDF Correlates With
AMP-AD Modules Enriched With
Inflammatory- and Neuronal-System
Associated Pathways

A hallmark of LOAD and other dementias is the loss of neurons,
particularly in the cortex and hippocampus. However, the cortical
and hippocampal neuronal cell loss is largely absent in the most
widely used mouse models of fAD and LOAD. Neuronal cell loss
was also not observed in LOAD1 mice, even at 24 months of
age (Kotredes et al., 2021). To assess the neuronal cell density in
this study, we examined both the cortex and the hippocampus
of CD and HFD animals from both LOAD1.Mthfr677C > T and
LOAD1.Plcg2M28L animals and controls utilizing fluorescent
immunostaining (Figures 2A–D and Supplementary Figure 1).
In both LOAD1.MthfrC677T and LOAD1.Plcg2M28L animals,
there was no quantitative difference in the density of neurons
in either genotype when comparing the CD to the HFD
(Figure 2). The second hallmark of LOAD is neuroinflammation,
particularly microglia activation. In our previous study, LOAD1
mice did not show microglia activation. When analyzing the
number of IBA1+ cells in the brain, compared to LOAD1
mice either on the CD or HFD, we found increased IBA1+

Hallmark pathologies, such as amyloid and tau accumulation
and neurodegeneration have been used widely to align mouse
models to human AD. However, more recently, molecular
approaches have been developed by MODEL-AD (Preuss et al.,
2020) and others that allow for a more precise assessment
of the relevance of mouse models to the molecular changes
observed in human LOAD (Allen et al., 2016; Mostafavi
et al., 2018; Wang et al., 2018; Wan et al., 2020). Here, we
correlated the effect of each mouse perturbation (sex, HFD,
genetic variants, and interaction between variants and HFD)
with 30 human AMP-AD co-expression modules (Wan et al.,
2020). These 30 modules, derived from different brain regions
and study cohorts, were grouped into five “consensus clusters”
based on similar gene content and repeated signals in the
multiple regions. Both risk variants, Mthfr677C > T and Plcg2M28L
exhibited significant positive correlations (p < 0.05) with cell
cycle and myelination-associated modules in Consensus Cluster
D and cellular stress-response associated modules in Consensus
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FIGURE 1 | Bodyweight, glucose, and cholesterol increased on a high fat/high sugar (HFD) diet, regardless of genotype. LOAD1, LOAD1.Mthfr 677C > T , and
LOAD1.Plcg2M28L mice were fed with a control diet (CD) or HFD from 2 to 12 months of age (A). At multiple timepoints throughout the study, blood was collected.
At the terminal time point, transcriptomics, limited neuropathology, and biochemical studies were completed. Over the course of the study, regardless of genotype or
sex, mice fed with HFD gained more weight than animals fed with a control diet (B). Glucose (D,E) and Cholesterol (F,G) increased over time, which was related to
diet, but not to genotype (C–F). A mixed ANOVA with repeated measures was completed; p < 0.05 is considered significant. *p < 0.05, **p < 0.01, ****p < 0.0001.
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FIGURE 2 | Neuron density is unaffected by HFD in LOAD1.Plcg2M28L and LOAD1.Mthfr 677C > T mice. Immunohistochemistry was completed using NeuN to
visualize the density of neurons (A–D) in the LOAD1.Plcg2M28L mice. The HFD has no significant effect on the density of neurons in either the cortex (E,G) or the
hippocampus (F,H) of either LOAD1.Plcg2M28L or LOAD1.Mthfr 677C > T mice. Statistical analysis was completed using an ANOVA followed by Tukey’s post hoc
tests. P < 0.05 is considered significant.
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FIGURE 3 | Microglial density is increased in LOAD1.Plcg2M28L high fat diet mice. Immunohistochemistry was completed using Iba1 to visualize the density of
microglia (A–D) in the LOAD1.Plcg2M28L mice. LOAD1.Mthfr 677C > T mice did not show any significant changes in microglia density in the cortex (E) or
hippocampus (F), regardless of diet. However, female LOAD1.Plcg2M28L was found to have an increase in the microglial density in the cortex of the mice fed with
HFD (G). No changes were observed in LOAD1.Plcg2M28L mice fed with the control diet (CD) (G,H). Data suggest a gene by diet interaction that may be
sex-specific. Statistical analysis was completed using an ANOVA followed by Tukey’s post hoc tests. P < 0.05 is considered significant.
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FIGURE 4 | Cytokine production is altered in mice fed with HFD. In order to identify peripheral factors that may be driving the genetic by diet interaction, we
examined the brain (A–F) and plasma (G–I) cytokines in both LOAD1.Plcg2M28L or LOAD1.Mthfr677C > T mice. In LOAD1 mice, significant increases in brain IL-1β
(A) and TNF-a (C) were observed in mice fed with HFD; however, LOAD1.Mthfr677C > T mice did not have any significant increases. In the LOAD1.Plcg2M28L mice,
a significant decrease in brain IL-1b (D) and IFN-g (E) was observed in the females, regardless of diet. The HFD did not show the same increase in the brain cytokine
levels as the control (LOAD1) animals, suggesting a deficiency in cytokines due to the variant. TNF-a was reduced in females as well (F), but only in the HFD group.
In the plasma of LOAD1.Plcg2M28L mice, we observed a reduction in IL-1b (G) and IFN-g (H) in male and female, respectively, LOAD1.Plcg2M28L mice. The TNF-a
was elevated in the HFD LOAD1.Plcg2M28L males only (I). Statistical analysis was completed using an ANOVA followed by Tukey’s post hoc tests. P < 0.05 is
considered significant.

Cluster E (Figure 4A). Moreover, Plcg2M28L displayed significant
positive correlation (p < 0.05) with neuronal system-associated
modules in Consensus Cluster C (Figure 5A). Furthermore,
Plcg2M28L displayed significant negative correlation (p < 0.05)
with immune-related modules in Consensus Cluster B, while
interaction between Plcg2M28L and HFD displayed significant
positive correlation (p < 0.05), suggesting interaction with HFD
increased neuroinflammation in mice carrying the Plcg2M28L
risk variant (Figure 5A). In addition, an interaction between
Plcg2M28L and HFD also exhibited significant positive correlation
(p < 0.05) with extracellular matrix organization- related module
in Consensus Cluster A and neuronal system-associated modules
in Consensus Cluster C (Figure 5A). Overall, we observed AD
relevant phenotypes in mice for an interaction between HFD and
Plcg2M28L risk variant.
We also correlated the effect of perturbation of each
mouse (HFD, genetic variants, and interaction between variants
and HFD) with 30 human AMP-AD co-expression modules
(Wan et al., 2020) for both sexes, separately. For both
male and female mice, we observed a significant positive
correlation between some of the immune-related modules in
Consensus Cluster B and interaction between Plcg2M28L and
HFD (Supplementary Figures 2A,B). However, the effects
were stronger in females as we observed a significant positive
correlation (p < 0.05) with immune modules associated with the
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PHG brain region as well in females, which was not significant
(p > 0.05) in male mice.
Genes exhibiting directional coherence between the effects
of interaction between HFD and Plcg2M28L in mice and change
in expression in AMP-AD modules in Consensus Clusters A
and B, respectively, were extracted. A total of 99 genes were
extracted that exhibited directional coherence for interaction
between HFD and Plcg2M28L in mice and change in expression
in AMP-AD modules in Consensus Cluster A, such as Aldh2,
Aldh6a1, Aldh7a1, lamb2, Rab31, and Sox9 (Supplementary File
3). We identified a total of 192 genes that exhibit a directional
coherence between interaction with HFD and Plcg2M28L in mice
and a change in the expression in immune-associated AMPAD modules in Consensus Cluster B, including microglia-related
genes, such as Trem2, Tyrobp, Cldn5, and C1qc (Figure 5E and
Supplementary File S3). To elucidate the role of these diseaserelated genes, we performed a KEGG pathway enrichment
analysis. Genes that showed directional coherence for the
interaction between HFD and Plcg2M28L in mice and human coexpression modules in Consensus Cluster A were enriched for
“Regulation of actin cytoskeleton,” “fatty acid degradation,” and
multiple “metabolism” associated pathways (Figure 5C). Genes
that showed directional coherence for interaction between HFD
and Plcg2M28L in mice and human co-expression modules in
Consensus Cluster B were enriched for multiple KEGG pathways,
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FIGURE 5 | Interaction between HFD and Plcg2M28L in mice exhibits transcriptional changes in immune function similar to human LOAD. (A) Correlation between
the effect of each mouse perturbation and 30 human co-expression modules. Each column represents one of the 30 human co-expression modules identified in
seven different brain regions: the dorsolateral prefrontal cortex (DLPFC), superior temporal gyrus (STG), frontal pole (FP), parahippocampal gyrus (PHG), temporal
cortex (TCX), inferior frontal gyrus (IFG), and cerebellum (CBE). These modules are grouped into five consensus clusters with similar gene content across the multiple
studies and brain regions. Note that HFD*Plcg2.M28L and HFD*Mthfr.C677T results denote interaction effects separated from the individual effects of diet and
variants. Controls for corresponding rows were therefore labeled N/A as the control is not strictly defined. Circles within a square correspond to significant (p < 0.05)
positive (blue) and negative (red) Pearson’s correlation coefficients. The color intensity and size of the circles are proportional to Pearson’s correlation coefficient.
(B) Correlation between the effect of each mouse perturbation and molecular subtypes of LOAD. The columns represent the two molecular subtypes associated
with LOAD in the Religious Orders Study and the Memory and Aging Project (ROSMAP) cohort, three molecular subtypes associated with LOAD in the Mayo cohort,
and two molecular subtypes associated with LOAD in the Mount Sinai Brain Bank (MSBB) cohort (Milind et al., 2020). The effects of interaction between HFD and
Plcg2M28L in mice significantly correlate with the inflammatory subtypes of LOAD (Subtypes A) in each of the cohorts. Circles within a square correspond to
significant (p < 0.05) positive (blue) and negative (red) Pearson’s correlation coefficients. (C) Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway
enrichment analysis (FDR adjusted p < 0.05) of genes exhibiting directional coherence between the effects of interaction between HFD and Plcg2M28L in mice and
ECM organization related AMP-AD modules in Consensus Cluster A. (D) KEGG Pathway enrichment analysis (FDR adjusted p < 0.05) of genes exhibiting directional
coherence between the effects of interaction between HFD and Plcg2M28L in mice and immune-related AMP-AD modules in Consensus Cluster B. (E) Identification
of genes exhibiting directional coherence for the interaction between HFD and Plcg2M28L in mice and change in the expression of immune-associated AMP-AD
modules in Consensus Cluster B, including microglia-related genes listed.

and MSBB cohorts (Figure 4B). Notably, the interaction between
HFD and Plcg2M28L risk variant showed a strong significant
positive correlation (p < 0.05) with the inflammatory subtypes
across all three cohorts, while no significant correlation was
observed for interaction between HFD and Mthfr677C > T risk
variant (Figure 5B).

such as “Tight junction,” “Hippo signaling pathway,” “Lysosome,”
and “phagocytosis” pathways (Figure 5D).

Interaction Between Risk Variant
Plcg2M28L and HFD Significantly
Correlates With Inflammatory LOAD
Subtypes

GESA Identified Upregulation of Multiple
Pathways of LOAD1.Plcg2M28L HFD
Animals but Not Mthfr677C > T

Next, to identify variants that resemble the inflammatory and
non-inflammatory subtypes in human patients, we correlated the
effect of each variant (sex, HFD, genetic variants, and interaction
between variants and HFD) with inflammatory and noninflammatory subtypes associated with LOAD in the ROSMAP,
MSBB, and Mayo cohorts (Allen et al., 2016; De Jager et al.,
2018, Wang et al., 2018). The effect of the Mthfr677C > T variant
showed a significant positive correlation (p < 0.05) with the
inflammatory subtypes across all three cohorts, while the effect
of Plcg2M28L and HFD showed a significant positive correlation
(p < 0.05) with the non-inflammatory subtype B in the ROSMAP
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Further, Nanostring AD panel genes were ranked based on
regression coefficients calculated for each factor, and GSEA
(Subramanian et al., 2005) was performed (refer to section
“Materials and Methods”). The GSEA identified upregulation
of Alzheimer’s disease, focal adhesion pathways in presence
of each perturbation except Mthfr677C > T (Supplementary
Figure 2). Multiple immune-related pathways were upregulated
and synaptic associated pathways, such as GABAergic synapse,
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results supported our hypothesis, with mice homozygous for
the Plcg2M28L risk variant on a LOAD1 background showing
more extreme AD phenotypes compared to either LOAD1
mice or LOAD1 mice homozygous for Mthfr677C > T . To our
knowledge, this is the first study to show that specific LOAD
risk variants interact with HFD to exacerbate LOAD phenotypes
whereas others do not.
Diet was provided from 2 to 12 months to model longterm exposure, from young adult to midlife, in the human
population. However, our study was not designed to determine
whether the changes are reversible. It is common that during
an individual’s lifetime, diet is varied, particularly as a part
of a weight loss program. People may go through periods of
healthy eating or short-term extreme “fad” diets, such as the
South Beach diet (Agatston, 2003) or the anti-inflammatory
Whole 30 diet (Hartwig, 2015). However, although the benefits
of changes in diet are observed for overt measures of health,
such as weight, cholesterol, and blood pressure, the effects of
changes in diet on the brain are not commonly tracked. Given
the similarity between the effects of an HFD in humans and
mice, studies where diet is varied during a lifetime, considering
factors, such as time on the diet and age, from which HFD
exposure began, should be performed. Here, the widely used
45% HFD (ResearchDiet feed D12451i) was used to mimic DIO.
This allowed for the effects of DIO to be determined within the
12 months of this study and further studies would be needed
to assess long-term effects in old age. In addition, B6 mice do
not develop overt type 2 diabetes when fed with an HFD, but
they are a model for early stages of the disease with phenotypes
that include obesity, mildly elevated non-fasting blood glucose,
increased serum glucose, glucose intolerance with advancing age
and elevated triglycerides, glucose, HDL, LDL, insulin, and leptin
(Collins et al., 2004)6 . Some of those changes were observed
in this study (Figure 1). However, a detailed assessment of
Type 2 diabetic phenotypes was not performed here. Therefore,
although we suggest not likely, we cannot rule out the interaction
between HFD and Plcg2M28L observed in the brain is due to
increased susceptibility to Type 2 diabetes in LOAD1.Plcg2M28L
compared to the other strains tested. Furthermore, the HFD
used here is somewhat extreme, not many individuals consume
45% fat daily. Therefore, to further align mouse studies to
the human situation, alternative diets should be tested, such
as a recently developed western diet that incorporates 16%
of fat that was designed to model the more common diet
consumed in the western world (Graham et al., 2016; Yang et al.,
2019).
In the present study, we found alterations in several
peripheral cytokines including IL-1β, IFN-γ, and TNF-α in only
the LOAD1.Plcg2M28L animals. In the LOAD1 and LOAD1.
Mthfr677C > T animals, TNF-a and IL-1b were upregulated
in LOAD1 animals fed HFD, but not the LOAD1.Plcg2M28L
animals. However, TNF-α, IL-1β, and IFN-γ were downregulated
in LOAD1.Plcg2M28L female brains, regardless of the diet.
Taken together, these data suggest the mechanisms driving
the interaction between HFD and Plcg2M28L may be due to a

and axon guidance were downregulated in the presence of HFD
and interaction between HFD and Plcg2M28L (Supplementary
Figure 1). Moreover, PCA using gene set enrichment score
(NES) revealed HFD as the main effect in mice. We observed
clear discrimination between genetic variants with and without
interaction with HFD along the first principal component
(accounting for around 59% of total variation) (Supplementary
Figure 2D). The second principal component accounts for
25% of the total variance and separated Mthfr677C > T and
interaction between HFD and Plcg2M28L factors from other
factors (Supplementary Figure 2).

Increased Brain Glycolysis and Perfusion
in Plcg2M28L HFD Animals
Due to the interaction between HFD and Plcg2M28L leading to
a transcriptomic inflammatory signature as well as an alteration
in tight junctions, it was important to determine if there were
any corresponding functional deficits. To visualize alterations
in regional glycolysis and perfusion, we performed in vivo
PET/CT imaging using 18 F-FDG (Figures 6A–C) and 64 CuPTSM (Figures 6D,E), respectively. Findings were confirmed
using autoradiography. PCA comparing sex, genotype, and
age determined 15 of the 27 brain regions that explained 80
percent of the variance in brain glycolysis in all mice and
all conditions (Figures 6B,C). Interestingly, an HFD mice
show overall increased glucose uptake compared to CD mice.
Utilizing PCA analysis again for blood flow analysis, 13 of
the 27 brain regions explained 80 percent of the variance
in blood flow in all mice and all conditions (Figures 6D,E).
Both tracers were utilized in the same animals; therefore,
autoradiographic studies were only performed at the terminal
scan (64 Cu-PTSM; Figures 6F,G). Interestingly, an HFD mice
showed overall increased perfusion compared to CD mice.
Several regions that showed increased glucose metabolism and
increased blood perfusion in a genotype-dependent manner
are involved in memory and behavior. These data support a
functional consequence of the observed interaction between HFD
and Plcg2M28L by IHC and transcriptomics.

DISCUSSION
Late-onset AD is a complex disorder that is caused by a
combination of genetic and environmental risk factors. However,
the specific combinations of genetic and environmental factors
that increase the risk for LOAD are not well understood.
In fact, it is likely that these vary between individuals,
making predictions of risk for LOAD based on their genetics
and exposures imprecise. Previous studies support this, with
E4FAD (APOE4+5xFAD) mice showing increased amyloid
deposition, specifically more compact plaques, compared to
E3FAD (APOE3+5xFAD) mice (Youmans et al., 2012). To
further explore gene by diet effects, in our study, three
new mouse models carrying different genetic risk factors for
LOAD were exposed to HFD for10 months (from 2 to 12
months) to test the hypothesis that the reported effects of
an HFD will vary depending on the genetic context. The
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FIGURE 6 | In vivo PET/CT imaging of LOAD1.Plcg2M28L fed with HFD. Representative images for 64 Cu-PTSM PET/CT and autoradiography of randomly selected
12-months old female LOAD1.Plcg2M28L mice following 10-month HFD treatment (A). In all cases, images are presented as standardized uptake value ratios
(SUVRs) to the cerebellum. Representative bregma image panel presented as average CT (left), PET (center-left), Fused (center-right), and Autoradiography (right).
Data presented are the brain regions that explain 80% of the variance determined using Principal Component Analysis (PCA) in brain glycolysis (B,C) and brain
perfusion (D,E) in both females (B,D) and males (C,E). Following the terminal 64 Cu-PTSM scans, the brains were subjected to autoradiographic analysis (F–G). Data
presented are the brain regions that explain 80% of the variance.
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Interestingly, the interaction between Mthfr677C > T and
HFD did not result in gene expression changes relating
to inflammation and therefore PET/CT was not performed
in LOAD1.Mthfr677C > T mice. MTHFR is a key enzyme
in the folate/methionine/homocysteine pathway. Variations in
MTHFR, particularly the Mthfr677C > T variant, are associated
with cardiovascular diseases, AD, and vascular dementia (Liu
et al., 2010; Liew and Gupta, 2015; Rai, 2017). In humans,
MTHFR677C > T reduces liver enzyme activity resulting in a
decrease in enzyme function. Common effects of this include
increases in homocysteine which is reported to increase the
risk for vascular inflammation and dysregulation. The MTHFR
is also expressed in multiple cells in the brain, particularly
in vascular-related cells, such as endothelial and vascular
smooth muscle cells. Supporting a role for MTHFR in the
cerebrovascular function, B6 mice homozygous or heterozygous
for Mthfr677C > T show reduced enzyme activity in both the
liver and brain, elevated levels of homocysteine, cerebral blood
flow deficits, reduced collagen 4 in the brain, and neurovascular
damage by electron microscopy (Reagan et al., 2021). However,
unlike Plcg2M28L , a function for MTHFR in microglia has
not been reported, further suggesting the interaction between
Plcg2M28L and HFD is driven by changes in microglial function.
Despite the increased alignment at the gene expression of
LOAD1.Plcg2M28L on an HFD to human LOAD compared
to strain-matched mice fed on CD, LOAD1.Plcg2M28L mice
fed on HFD still lack amyloid-beta plaques. This is not
surprising as mice require mutations or engineering of the
human sequence to drive plaque deposition, neither of which
are present in these mice. Notably, this allows us to study
the effect of LOAD genetic risk x aging in the absence of
amyloid pathology. Also, neuronal loss was not detected in
LOAD1.Plcg2M28L mice on an HFD, at least in the brain
regions assessed up to 12 months of age, suggesting additional
pathways/processes need to be perturbed likely in combination
with extended aging to further align these models to human
LOAD. The presence of age-dependent amyloid accumulation
would be expected to further modify LOAD phenotypes and
possibly result in neuronal cell loss. Therefore, a humanized
amyloid-beta (hAb) allele has been created by MODEL-AD and
added to LOAD1 (to create LOAD2; B6.APOE4.Trem2R47H .hAb)
and to LOAD1.Plcg2M28L and LOAD1.Mthfr677C > T to create
LOAD2.Plcg2M28L and LOAD2.MthfrC677T , respectively. Male
and female test and control mice are provided with HFD
and aged from 18 to 24 months to determine the longterm effects of combining APOE4, Trem2R47H , Plcg2M28L , or
Mthfr677C > T risk variants in combination with aging and the
more amyloidogenic humanized hAb.
Despite the fact that all mice carried the APOE4 and
Trem2R47H variants, linear modeling identified the specific
effects of the Plcg2M28L and Mthfr677C > T variants and the
Plcg2M28L :HFD and Mthfr677C > T :HFD interactions. However,
data now suggest that although APOE4 and TREM2R47H are
strong genetic risk factors for LOAD in humans, TREM2R47H
may be reducing the effect of the APOE4 variant when present
together (Kotredes et al., 2021). This may be due in part to

combination of peripheral and central factors (likely involving
microglia responses) that conspire to increase the alignment of
brain transcriptomes to human LOAD.
The interaction between Plcg2M28L and HFD was determined
using the Nanostring Mouse AD panel. These analyses indicated
Plcg2M28L :HFD (interaction) resulted in changes in the
expression of genes enriched for inflammatory pathways.
The direction of the changes correlated with gene expression
changes observed in human AD based on the AMP-AD
modules (Preuss et al., 2020). Many of these “inflammation”
genes are expressed by microglia including Csf1, Tgfbr2,
Fcer1g, Trem2, and Tyrobp. PLCG2 is a critical signaling
element for various immune receptors and is a key regulatory
hub gene for immune signaling. The PLCG2 is expected
to be important in AD due to the previous findings that
suggest that a hypermorphic variant in PLCG2, rs72824905,
is protective against AD risk. However, the role of PLCG2
has not yet been comprehensively explored (Tsai et al., 2021;
Maguire et al., 2021). A previous study has reported that
reduced PLCG2 gene expression alters microglial phenotypes
in 5XFAD mice, affects plaque pathology, and drives distinct
transcriptional phenotypes of microglia in the presence of
amyloid pathology (Tsai et al., 2021). The HFD used here is
reported to create a more inflammatory environment in the
brain, causing microglia activation. Previous HFD studies
have been associated with increased microglial activity in
wild-type mice (Rivera et al., 2013; Wanrooy et al., 2018). In
the present study, transcriptomic changes were observed in
the neuroinflammation module, indicative of alterations in
the microglial function. Consistent with the transcriptomic
changes, this study revealed an increase in microgliosis in
the hippocampus of LOAD1.Plcg2M28L mice, but not in
LOAD1.Mthfr677C > T . As with all studies involving mouse
models, these findings can be further supported using alternative
approaches in humans and/or cell-based models (e.g., human
iPSC-derived microglia), given some reports that indicate
differences in microglia responses between humans and mice
(Streit et al., 2009; Navarro et al., 2018; Streit et al., 2018; Olah
et al., 2020).
Recent in vivo imaging studies have suggested that microglia
displayed higher glucose uptake than neurons and astrocytes
(Xiang et al., 2021). In patients with AD, glucose uptake was
measured using FDG-PET, and increases in glucose uptake were
observed with an increase in the microglial activity (utilizing
TSPO-PET) (Xiang et al., 2021). In the present study, we
observed alterations in FDG activity in multiple brain areas
in LOAD1.Plcg2M28L mice. It is possible that the predicted
loss of function of this variant alters the microglial state,
leading to a dampened FDG signal and reduced function,
which would agree with the reduced cytokine release that was
observed in the brain tissue. Although we observed increases
in the microglial number in female LOAD1.Plcg2M28L mice,
this was only in the hippocampus of HFD animals, suggesting
a potential compensatory effect. The present study suggests
that FDG-PET may provide evidence for the microglial state
in vivo.
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the reduced expression levels of Trem2 in Trem2R47H mice caused
by a cryptic splice site that results in an aberrant splice form
(JAX#27918). MODEL-AD has created a new Trem2R47H allele
(Trem2∗ R47H HSS ) that incorporates a human splice site (HSS)
and restores Trem2 expression to normal levels, at least in young
wild type B6 mice (JAX#33781). Future studies will incorporate
APOE4 or Trem2∗ R47H HSS in combination with the hAb allele
and a recently created humanized, MAPT-GR (JAX # 35398 and
33668) to study the interaction between HFD and Tau pathology
in the context of LOAD. These mice express the human MAPT
(H1 or H2 haplotype, respectively) and MAPT-AS1 transcripts
and the typical MAPT protein isoforms.
In summary, combining genetic and environmental risk
factors (e.g., HFD) leads to better translational and preclinical
models of LOAD. The interactions we have observed here
that correlate with LOAD in the human population suggest
that the effects of an HFD are genotype-specific and further
investigation is needed to resolve the mechanistic interactions
between genetics and diet.
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